Bone Loss Treatment From Adjuvant Zoledronate Efficacy
Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to observe and assess the impact of adjuvant zoledronate on
bone density in breast cancer patients.
The second purposes:
- The efficacy of adjuvant zoledronate
- The safety of adjuvant zoledronate
- The bone loss of breast cancer patients in Guangdong
- The correlation between bone loss of breast cancer patients and treatment of disease in
Guangdong